The Effect of Rebamipide for the Patients with Reflux Esophagitis and Gastritis.
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Rebamipide (Primary) ; Esomeprazole
- Indications Gastritis; Reflux oesophagitis
- Focus Therapeutic Use
- 05 Jun 2016 Planned number of patients changed from 450 to 492.
- 05 Jun 2016 Status changed from recruiting to completed.
- 06 Dec 2013 Planned number of patients changed from 260 to 240 as reported by University Hospital Medical Information Network - Japan.